JTL — Jayex Technology Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- AU$1.41m
- AU$4.93m
- AU$3.48m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.4 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -121.77% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 7.18 | 5.07 | 3.59 | 4.3 | 3.48 | n/a | n/a | -12.39% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Jayex Technology Limited is an Australia-based company engaged in the development and provision of healthcare industry service technologies, and the development of integrated dispensing automation systems for the pharmaceutical and healthcare sectors. The Company's segments include Australia and United Kingdom. Its products include Jayex Connect and Enlighten. Jayex Connect is a cloud-based patient engagement platform, which is made up of five modules, such as CONNECT, ARRIVE, DISPLAY, APPOINTUIT, CAMPAIGN AND SURVEY, each targeting at a specific aspect of patient management. Enlighten is a patient workflow platform, which is designed to enhance patients experience while providing friction-free check-in process for patients. Its platform capabilities include appointment booking, patient calling, patient check-in, through to health messaging, self-care monitoring, script management, remote terminal dispensing of pharmaceutical and/or medical cannabis products and telehealth solutions.
Directors
- Michael Boyd CHM (55)
- Gordon Cooper CFD
- Rosemary Cooper CFD
- Cameron Knox CFO
- Robert Mantel CEX
- Michael Chan NED
- Brian Renwick NED
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 4th, 2006
- Public Since
- December 17th, 2015
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 281,278,539
- Address
- 17B Cribb Street, Milton, BRISBANE, 4064
- Web
- https://www.jayex.com/
- Phone
- +61 300330611
- Auditors
- William Buck Audit (Vic) Pty Ltd
Upcoming Events for JTL
Half Year 2024 Jayex Technology Ltd Earnings Release
Similar to JTL
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Allegra Medical Technologies
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
FAQ
What is the Jayex Technology share price?
As of Today at 19:12 UTC, shares in Jayex Technology are trading at AU$0.01. This share price information is delayed by 15 minutes.
How has the Jayex Technology share price performed this year?
Shares in Jayex Technology last closed at AU$0.01 and the price had moved by -44.44% over the past 365 days. In terms of relative price strength the Jayex Technology share price has underperformed the ASX All Ordinaries Index by -46.86% over the past year.
What are the analyst and broker recommendations for Jayex Technology?
There is no consensus recommendation for this security.
What is the Jayex Technology dividend yield?
Jayex Technology does not currently pay a dividend.
Does Jayex Technology pay a dividend?
Jayex Technology does not currently pay a dividend.
When does Jayex Technology next pay dividends?
Jayex Technology does not currently pay a dividend.
How do I buy Jayex Technology shares?
To buy shares in Jayex Technology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Jayex Technology?
As of the previous close price of AU$0.01, shares in Jayex Technology had a market capitalisation of AU$1.41m.
Where are Jayex Technology shares listed?
Here are the trading details for Jayex Technology:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: JTL
What kind of share is Jayex Technology?
Based on an overall assessment of its quality, value and momentum Jayex Technology is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Jayex Technology share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Jayex Technology share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Jayex Technology. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -44.38%.
As of the last closing price of AU$0.01, shares in Jayex Technology were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Jayex Technology PE Ratio?
The Jayex Technology PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Jayex Technology?
Jayex Technology's management team is headed by:
- Michael Boyd - CHM
- Gordon Cooper - CFD
- Rosemary Cooper - CFD
- Cameron Knox - CFO
- Robert Mantel - CEX
- Michael Chan - NED
- Brian Renwick - NED